Australian guidelines for cost-effectiveness studies of pharmaceuticals: the thin end of the boomerang?

Preprint OPEN
Mike Drummond; (1991)
  • Subject: pharmaceutical industry, Australia, medicines

In the summer of 1990, the Australian government took a major step by requiring evidence of cost-effectiveness of new medicines prior to reimbursement by the public health care system. This paper assesses whether the methodological principles behind the guidelines are s... View more
Share - Bookmark